JYNT

$JYNT Share Price: $8.83 Contract Selected: Jan 15, 2027 $10 Calls Buy Zone: $1.32 – $1.63 Target Zone: $2.46 – $3.01 Potential Upside: 77% ROI Time to Expiration: 238 Days | Updates via https://fxcapta.com/stockinfo/

$JYNT elected Milind Pant to its board, adding franchise and international growth expertise.

$JYNT extended its revolving credit facility maturity to August 2029 with a fourth amendment that also waives a covenant default.

$JYNT Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.09 up 50.00% YoY • Reported revenue of $14.82M up 13.33% YoY • The Joint Corp. reiterated its 2026 guidance, expecting system-wide sales between $519M and $552M, system-wide comp sales from (3)% to 3%, and consolidated Adjusted EBITDA between $12.5M and $13.5M.

$JYNT updated investors on its planned sale of 45 Southern California clinics to Elite Chiro Group.

$JYNT Current Stock Price: $9.11 Contracts to trade: $10.0 JYNT May 15 2026 Call Entry: $0.23 Exit: $0.38 ROI: 67% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

$JYNT Company is undervalued. 25M in cash, no debt and returning to profitability. Buy now for a double.

$JYNT named Michelle Hirons as chief financial officer.

$JYNT down 3+% on a day where the indexes are melting faces. Not good. This company eventually will go to zero.

$JYNT bottom is in. Should start upward momentum with some upgrades to 10-12 range

$JYNT Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.07 • Reported revenue of $15.17M up 4.99% YoY • The Joint Corp. expects 2026 system-wide sales between $519M and $552M, with consolidated Adjusted EBITDA projected from $12.5M to $13.5M. New franchised clinic openings are anticipated to be 30 to 35.

$JYNT Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.07 • Reported revenue of $15.17M up 4.99% YoY • The Joint Corp. expects 2026 system-wide sales between $519M and $552M, with consolidated Adjusted EBITDA projected at $12.5 million to $13.5 million. System-wide comp sales are guided to be (3)% to 3%.